New research provides preliminary evidence that psychedelic drugs can improve mental health by making individuals more accepting of distressing experiences. The study, published in Frontiers in Psychiatry, adds to a growing body of literature that indicates using substances like psilocybin can result in sustain improvements in depressive symptoms.
“Psychedelic therapy has shown promise as a novel treatment for a range of mental health concerns, including major depressive disorder, distress associated with a life-threatening illness, and substance use disorders,” said study author Richard Zeifman, a PhD student at Ryerson University and research intern at the Centre for Psychedelic Research at Imperial College London.
“In contrast with the traditional pharmacological interventions, the effects of psychedelic therapy appear to last months and even years after treatment has ended. Understanding how psychedelic therapy leads to long-lasting mental health improvements across a range of conditions is not yet fully understood but is important for enhancing and delivering psychedelic therapy to individuals that may benefit from it.”
Published: August 13, 2020